Nato a Torino il 16/09/1973.
1992 Diploma di Maturità presso il Liceo Scientifico Marie Curie (Grugliasco, Torino).
1998 Laurea in Medicina e Chirurgia presso l’Università degli Studi di Torino con votazione di 110
e lode/110 e Menzione Onorevole (Tesi Degna di Stampa).
2001 Vincitore di Borsa di Studio assegnata, dopo valutazione comparativa dei titoli, dalla
Fondazione Trentina per la Ricerca sui Tumori a medici operanti nel settore oncologico e
radioterapico.
2002 Diploma di Specializzazione in Radioterapia Oncologica presso l’Università degli Studi di
Torino con votazione di 70 e lode/70 (Tesi Degna di Stampa).
2006 Diploma di Specializzazione in Radiodiagnostica presso l’Università degli Studi di Torino con
votazione di 70 e lode/70 (Tesi Degna di Stampa).
2007-2022 In servizio di ruolo presso l’Azienda Sanitaria Ospedaliero-Universitaria San Luigi
Gonzaga di Orbassano (Torino), a tempo pieno, nel profilo di Dirigente Medico di Radiodiagnostica
a decorrere da febbraio 2007 sino a dicembre 2022.
2023 Medico radiologo in regime di libera professione da gennaio 2023.
Membro della SIRM (Società Italiana di Radiologia Medica)
Membro della ESR (European Society of Radiology).
2
L’attività clinica ed assistenziale è caratterizzata dalla continuità temporale e dall’essersi espletata
frequentando pressoché tutte le Sezioni, i Servizi generali e Speciali del Reparto Radiologico. Nello
specifico ha maturato esperienza ventennale nel campo dell’ecografia clinica in ambito internistico
(addominale, urologica, endocrinologica) e ortopedico-traumatologico (muscolo-scheletrica, osteoarticolare, parti molli/tessuti superficiali).
L’attività scientifico-didattica è corroborata dalla partecipazione a diversi Corsi di aggiornamento in
Radiologia Diagnostica, Simposi e Workshop, in ambito Nazionale ed Internazionale. Ha
relazionato, quale coautore, comunicazioni scientifiche al ECR (European Congress of Radiology,
Vienna) e al RSNA (Radiologic Society of North America, Chicago). Ha inoltre attivamente
partecipato a Sperimentazioni Cliniche quale Investigator in protocolli clinici.
Nel periodo trascorso, per quanto attiene l’attività di ricerca, si è espresso come autore o coautore in
66 lavori in extenso, pubblicati su riviste a severo controllo redazionale con Impact Factor, in 44
comunicazioni a congressi, anche con relazione su invito, e in 1 Capitolo di Libro. Ha ricevuto
invito ad attività di reviewer per riviste internazionali a severo controllo redazionale con Impact
Factor.
Pubblicazioni scientifiche in extenso edite su Rivista
Per quanto concerne la produzione scientifica, il sottoscritto ha pubblicato 66 articoli in extenso su
riviste internazionali a severo controllo redazionale (tra le più importanti “Radiology” della
Radiologic Society of North America e “European Radiology” della European Society of
Radiology), ottenendo ad oggi 962 citazioni con h-index pari a 18 (www.scopus.com, accesso
internet del 1 gennaio 2023).
1. Priola AM, Priola SM. Importance of measurement repeatability of semi-quantitative imaging through PETCT and PET-MR imaging in oncology. Transl Cancer Res 2019;8(7):2510-2513. doi:
10.21037/tcr.2019.05.15
2. Priola AM, Gned D, Veltri A, Priola SM. Case 261: Thymoma embedded in thymus with pleural implant in
myasthenia gravis Lambert-Eaton overlap syndrome. Radiology 2019;290:264-269. doi:
10.1148/radiol.2018161761
3. Priola AM, Priola SM. Morphological assessment of thymic carcinoma through imaging: is computed
tomography useful in selecting patients for surgery and in predicting incomplete resection? J Thorac Dis
2018;10(Suppl 33):S3933-S3937. doi: 10.21037/jtd.2018.09.97
4. Osella G, Priola AM, Priola SM, Piga A, Longo F, Ventura M, Bentivegna G, Angeli A, Veltri A, Terzolo M.
Dual-energy X-ray absorptiometry predictors of vertebral deformities in beta-thalassemia major. J Clin
Densitom 2018;21(4):507-516. doi: 10.1016/j.jocd.2017.06.028
5. Priola AM, Gned D, Veltri A, Priola SM. Case 261. Radiology 2018;288:898-900. doi:
10.1148/radiol.2018161760
6. Priola AM, Veltri A, Priola SM. Perfusion bias in the apparent diffusion coefficient measurements of
diffusion-weighted magnetic resonance imaging. Tumori 2018;104(4):315. doi: 10.5301/tj.5000650
7. Priola AM, Veltri A, Priola SM. Mediastinal and pleural MR imaging in daily practice. Radiographics
2018;38(3):981-982. doi: 10.1148/rg.2018180011
3
8. Priola AM, Priola SM, Gned D, Giraudo MT, Veltri A. Nonsuppressing normal thymus on chemical-shift MR
imaging and anterior mediastinal lymphoma: differentiation with diffusion-weighted MR imaging by using the
apparent diffusion coefficient. Eur Radiol 2018;28:1427-1437. doi: 10.1007/s00330-017-5142-z
9. Priola AM, Priola SM, Gned D, Giraudo MT, Brundu M, Righi L, Veltri A. Diffusion-weighted quantitative
MRI of pleural abnormalities: intra- and interobserver variability in the apparent diffusion coefficient
measurements. J Magn Reson Imaging 2017;46:769-782. doi: 10.1002/jmri.26633
10. Priola AM, Veltri A, Priola SM. CT perfusion in characterizing anterior mediastinal solid tumors. Diagn
Interv Radiol 2017;23:331-332. doi: 10.5152/dir.2017.011
11. Priola AM, Priola SM. Impact of measurement time on clinical workflow in different manual methods of
region of interest positioning for ADC quantification. Radiology 2017;284(1):298-299. doi:
10.1148/radiol.2017170270
12. Priola AM, Priola SM, Parlatano D, Gned D, Giraudo MT, Giardino R, Ferrero B, Ardissone F, Veltri A.
Apparent diffusion coefficient measurements in diffusion-weighted magnetic resonance imaging of the anterior
mediastinum: inter-observer reproducibility of five different methods of region-of-interest positioning. Eur
Radiol 2017;27:1386-1394. doi: 10.1007/s00330-016-4527-8
13. Priola AM, Veltri A, Priola SM. Myasthenia gravis. N Engl J Med 2017;30;376(13):e25. doi:
10.1056/NEJMc1701027
14. Priola AM, Priola SM, Gned D, Piacibello E, Sardo D, Parvis G, Torti D, Ardissone F, Veltri A. Diffusionweighted quantitative MRI to diagnose benign conditions from malignancies of the anterior mediastinum:
Improvement of diagnostic accuracy by comparing perfusion-free to perfusion-sensitive measurements of the
apparent diffusion coefficient. J Magn Reson Imaging 2016;44:758-769. doi: 10.1002/jmri.25203
15. Priola AM, Priola SM. Consideration about the ability of computed tomography to predict the clinical stage of
thymoma. Eur J Cardiothorac Surg 2016;50(3):584-585. doi: 10.1093/ejcts/ezw080
16. Priola AM, Veltri A, Priola SM. Re: Initial experience of 18F-FDG PET/MRI in thymic epithelial tumors:
morphologic, functional, and metabolic biomarkers. Clin Nucl Med 2016;41(9):748.
doi:10.1097/RLU.0000000000001301
17. Priola AM, Priola SM. Is it time to increase the use of nonvascular thoracic MR imaging in clinical practice in
lieu of CT? Radiology 2016;281(1):320-321. doi: 10.1148/radiol.2016160840
18. Priola AM, Veltri A, Priola SM. Importance of different region-of-interest protocols for the apparent diffusion
coefficient measurement of tumors in diffusion-weighted magnetic resonance imaging. J Magn Reson
Imaging 2016;44(4):1056. doi: 10.1002/jmri.25190
19. Priola AM, Veltri A, Priola SM. Diffusion-weighted MR imaging for characterizing mediastinal lymph nodes
in children. Jpn J Radiol 2016;34:383-384. doi: 10.1007/s11604-015-0487-1
20. Priola AM, Priola SM. Is computed tomography really reliable in differentiating of thymomas according to the
Masaoka-Koga staging system? Ann Thorac Surg 2016;101(5):2022. doi: 10.1016/j.athoracsur.2015.10.062
21. Priola AM, Priola SM, Gned D, Giraudo MT, Fornari A, Veltri A. Comparison of CT and chemical-shift MRI
for differentiating thymoma from non-thymomatous conditions in myasthenia gravis: value of qualitative and
quantitative assessment. Clin Radiol 2016;71:e157-e169. doi: 10.1016/j.crad.2015.12.009
22. Cistaro A, Cucinotta M, Cassalia L, Priola A, Priola S, Pappalardo M, Coppolino P, De Simone M, Quartuccio
N. 18F-FDG PET/CT, cytoreductive surgery and intraperitoneal chemohyperthermia for the therapeutic
management in peritoneal carcinomatosis: A pilot study. Rev Esp Med Nucl Imagen Mol 2016;35(4):232-
237. doi: 10.1016/j.remn.2016.01.001
23. Priola AM, Priola SM, Giraudo MT, Gned D, Fornari A, Ferrero B, Ducco L, Veltri A. Diffusion-weighted
magnetic resonance imaging of thymoma: ability of the Apparent Diffusion Coefficient in predicting the
4
World Health Organization (WHO) classification and the Masaoka-Koga staging system and its prognostic
significance on disease-free survival. Eur Radiol 2016;26:2126-2138. doi: 10.1007/s00330-015-4031-6
24. Priola AM, Priola SM. Re: Anterior mediastinal solid tumours in adults: characterisation using dynamic
contrast-enhanced MRI, diffusion-weighted MRI, and FDG-PET/CT. Clin Radiol 2016;71(7):713-715. doi:
10.1016/j.crad.2016.02.027
25. Priola AM, Priola SM. Author’s reply to: Diffusion-weighted MRI in thymomas. Tumori 2016;102(1):e5.
doi: 10.5301/tj.5000409
26. Priola AM, Gned D, Veltri A, Priola SM. Chemical shift and diffusion-weighted magnetic resonance imaging
of the anterior mediastinum in oncology: Current clinical applications in qualitative and quantitative
assessment. Crit Rev Oncol Hematol 2016;98:335-357. doi: 10.1016/j.critrevonc.2015.11.012
27. Cardinale L, Priola AM, Priola SM, Boccuzzi F, Dervishi N, Lisi E, Veltri A, Ardissone F. Radiological
contribution to the diagnosis of early postoperative complications after lung resection for primary tumor: a
revisional study. J Thorac Dis 2016;8(8):E643-E652. doi: 10.21037/jtd.2016.07.02
28. Priola AM, Priola SM. Thymoma of the left thymic lobe with a contralateral small pleural implant
successfully detected with diffusion-weighted MRI. Tumori 2015:101(1):e13-e17. doi: 10.5301/tj.5000199
29. Priola AM, Priola SM. Usefulness of diffusion-weighted MR imaging in predicting Masaoka-Koga clinical
staging of thymic epithelial tumors by using the apparent diffusion coefficient. Radiology 2015:274(3):936-
937. doi: 10.1148/radiol.14141528
30. Priola AM, Gned D, Marci V, Veltri A, Priola SM. Diffusion-weighted MRI in a case of nonsuppressing
rebound thymic hyperplasia on chemical-shift MRI. Jpn J Radiol 2015;33:158-163. doi: 10.1007/s11604-014-
0388-8
31. Priola AM, Priola SM, Ciccone G, Evangelista A, Cataldi A, Gned D, Pazè F, Ducco L, Moretti F, Brundu M,
Veltri A. Differentiation of rebound and lymphoid thymic hyperplasia from anterior mediastinal tumors with
dual-echo chemical-shift MR imaging in adulthood: reliability of the chemical-shift ratio and signal intensity
index. Radiology 2015;274(1):238-249. doi: 10.1148/radiol.14132665
32. Priola AM, Priola SM, Giraudo MT. Usefulness of CT in differentiating lymphoid thymic hyperplasia from
true thymic hyperplasia: added value of thymic measurements and CT attenuation. AJR American Journal of
Roentgenology 2015;204:W113-114. doi: 10.2214/AJR.14.13254
33. Priola AM, Gned D, Parvis G, Torti D, Priola SM. Usefulness of diffusion-weighted magnetic resonance
imaging for assessing early treatment response in lymphoma patients. Acta Radiol 2015;56(2):NP10-NP11.
doi: 10.1177/0284185114554254
34. Priola AM, Priola SM, Giraudo MT, Gned D, Giardino R, Marci V, Errico L, Veltri A. Chemical-shift and
diffusion-weighted magnetic resonance imaging of thymus in myasthenia gravis: usefulness of quantitative
assessment. Invest Radiol 2015;50(4):228-238. doi: 10.1097/RLI.0000000000000120
35. Priola AM, Priola SM. Chemical-shift MRI of rebound thymic hyperplasia with unusual appearance and
intense (18)F-FDG uptake in adulthood: report of two cases. Clin Imaging 2014;38:739-742. doi:
10.1016/j.clinimag.2014.02.010
36. Priola AM, Galetto G, Priola SM. Diagnostic and functional imaging of thymic and mediastinal involvement
in lymphoproliferative disorders. Clin Imaging 2014;38:771-784. doi: 10.1016/j.clinimag.2014.05.012
37. Priola AM, Priola SM. Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor.
Clin Radiol 2014;69:e230-e245. doi: 10.1016/j.crad.2014.01.005
38. Priola AM, Gned D, Veltri A, Priola SM. Case 204: Non-ketotic hyperpglycemia-induced
hemiballism/hemichorea. Radiology 2014;271:304-308. doi: 10.1148/radiol.14120840
5
39. Priola AM, Priola SM, Volpicelli G, Giraudo MT, Martino V, Fava C, Veltri A. Accuracy of 64-row multi
detector CT in the diagnosis of surgically treated acute abdomen. Clin Imaging 2013;37:902-907. doi:
10.1016/j.clinimag.2013.02.016
40. Priola AM, Priola SM, Giaj-Levra M, Basso E, Veltri A, Fava C, Cardinale L. Clinical implications and added
costs of incidental findings in an early detection study of lung cancer by using low-dose spiral computed
tomography. Clin Lung Cancer 2013;14:139-148. 10.1016/j.cllc.2012.05.005
41. Priola AM, Priola SM. Early pancreatic splenosis presented 2 years after splenectomy. Clin Imaging
2013;37:780-782. doi: 10.1016/j.clinimag.2013.01.002
42. Priola AM, Priola SM. Influence of selected b value on ADC quantification in diffusion-weighted MRI.
Comment on Punwani et al.: Diffusion-weighted MRI of lymphoma: prognostic utility and implications for
PET/MRI? Eur J Nucl Med Mol Imaging 2013;40:1108-1109. doi: 10.1007/s00259-013-2390-2
43. Priola AM, Gned D, Veltri A, Priola SM. Case 204. Radiology 2013;269:938-939. doi:
10.1148/radiol.13120839
44. Priola AM, Priola SM. Computed tomography-guided needle biopsy of lung lesions: is fine needle aspiration
really more accurate than core needle biopsy? Acta Radiol 2013;54:1150-1151. doi:
10.1177/0284185113502476
45. De Pascale A, Piccoli GB, Priola SM, Rognone D, Consiglio V, Garetto I, Rizzo L, Veltri A. Diffusionweighted magnetic resonance imaging: New perspectives in the diagnostic pathway of non-complicated acute
pyelonephritis. Eur Radiol 2013;23:3077-3086. doi: 10.1007/s00330-013-2906-y
46. Priola AM, Veltri A, Priola SM. FDG PET/CT for the evaluation of normal thymus, lymphoma recurrence,
and mediastinal lymphoma in pediatric patients. Radiology 2012;264(3):918-919. doi:
10.1148/radiol.12120724
47. Priola AM, Gned D, Boccuzzi F, Priola SM. Unusual focal intrahepatic extramedullary haematopoiesis in
alpha-thalassaemia. Liver Int 2012;32:771. doi: 10.1111/j.1478-3231.2012.02759.x
48. Priola AM, Gned D, Veltri A, Priola SM. A 30-year-old man with sickle-cell disease and severe dyspnea from
transfusion-related acute lung injury. Respir Care 2012;57:2124-2126. doi: 10.4187/respcare.01841
49. Priola AM, Priola SM: Patent foramen ovale and paradoxical cerebral embolism in a young woman. Intern
Med J 2011;41:755-756. doi: 10.1111/j.1445-5994.2011.02577.x
50. Priola AM, Priola SM, Volpicelli G: Late presentation of ureteral injury following laparoscopic colorectal
surgery. JBR-BTR 2011;94:196-198. doi: 10.5334/jbr-btr.585
51. Priola AM, Priola SM: Retained intra-abdominal surgical instrument: a rare condition of acute abdomen. ANZ
J Surg 2010;80:758. doi: 10.1111/j.1445-2197.2010.05469.x
52. Priola AM, Priola SM, Cataldi A, Di Franco M, Pazè F, Marci V, Berruti A: Diagnostic accuracy and
complication rate of CT-guided fine needle aspiration biopsy of lung lesions: a study based on the experience
of the cytopathologist. Acta Radiol 2010;51:527-533. doi: 10.3109/02841851003691979
53. Priola AM, Priola SM, Di Franco M, Cataldi A, Durando S, Fava C: Computed Tomography and thymoma:
distinctive findings in invasive and noninvasive thymoma and predictive features of recurrence. Radiol Med
2010;115:1-21. doi: 10.1007/s11547-009-0478-3
54. Priola AM, Priola SM, Cataldi A, Fava C, Volpicelli G: A case of epigastric pain in the ED: late mechanical
complication after vertical banded gastroplasty. Am J Emerg Med 2009;27(5):633.e5-633.e7. doi:
10.1016/j.ajem.2008.09.018
55. Priola AM, Priola SM: Primary mediastinal Hodgkin lymphoma and rebound thymic hyperplasia:
differentiation with chemical-shift magnetic resonance imaging after treatment. Int J Hematol 2009;90:8-10.
doi: 10.1007/s12185-009-0357-7
6
56. Priola AM, Priola SM, Cataldi A, Marci V, Fava C: Acute abdomen as an unusual presentation of hepatic
PEComa. A case report. Tumori 2009;95(1):123-128. PMID: 19366072
57. Priola AM, Picciotto G, Priola SM: Diffuse abdominal splenosis: a condition mimicking abdominal
lymphoma. Int J Hematol 2009;90(5):543-544. doi: 10.1007/s12185-009-0454-7
58. Cardinale L, Volpicelli G, Binello F, Garofalo G, Priola SM, Veltri A, Fava C. Clinical application of lung
ultrasound in patients with acute dyspnoea: Differential diagnosis between cardiogenic and pulmonary causes.
Radiol Med 2009;114:1053-1064.
59. Priola AM, Priola SM, Cataldi A, Ferrero B, Garofalo G, Errico L, Marci V, Fava C: CT guided percutaneous
transthoracic biopsy in the diagnosis of mediastinal masses: evaluation of 73 procedures. Radiol Med
2008;113:3-15. doi: 10.1007/s11547-008-0233-1
60. Priola AM, Priola SM, Cataldi A, Errico L, Di Franco M, Campisi P, Molinaro L, Marci V, Novello S, Fava
C: Accuracy of CT-guided transthoracic needle biopsy of lung lesions: factors affecting diagnostic yield.
Radiol Med 2007;112:1142-1159. doi: 10.1007/s11547-007-0212-y
61. Cardinale L, Giaj Levra M, Novello S, Priola AM, Priola SM, Sardo D, Fava C. Low-dose spiral computer
tomography screening for lung cancer. Minerva Pneumol 2007;46(3):235-242.
62. Priola SM, Priola AM, Cataldi A, Fava C: Nodular sclerosing Hodgkin disease presenting as a sternal mass.
Br J Haematol 2006;135:594. doi: 10.1111/j.1365-2141.2006.06305.x
63. Priola AM, Priola SM, Cardinale L, Cataldi A, Fava C: The anterior mediastinum: Diseases. Radiol Med
2006;111:312-342. doi: 10.1007/s11547-006-0032-5
64. Priola SM, Priola AM, Cardinale L, Perotto F, Fava C: The anterior mediastinum: Anatomy and imaging
procedures. Radiol Med 2006;111:295-311. doi: 10.1007/s11547-006-0031-6
65. De Pascale A, Garofalo G, Perna M, Priola S, Fava C. Contrast-enhanced ultrasonography in Crohn’s disease.
Radiol Med 2006;111:539-550. doi: 10.1007/s11547-006-0049-9.
66. Priola AM, Priola SM: True Love Is in the Air. Heart Rendering. RadioGraphics 2005;25:284
